VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹64 Cr | ₹60 Cr | ₹60 Cr | ₹62 Cr | ₹54 Cr |
What is the latest Operating Profit of VENUS REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹64 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹54 Cr |
How is Operating Profit of VENUS REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹64 Cr | 6.59 | |
| Mar2024 | ₹60 Cr | -0.71 | |
| Mar2023 | ₹60 Cr | -3.36 | |
| Mar2022 | ₹62 Cr | 15.50 | |
| Mar2021 | ₹54 Cr | - | |
Compare Operating Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,365.8 Cr | -9.3% | 24.8% | 312.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -9.3% |
24.8% |
312.9% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses